Clinical Trials

Study Title:
A Phase 1/2 Study of NM21 1480 (Anti PDL 1/Anti 4 1BB/Anti HSA Tri Specific Antibody) in Adult Patients With Advanced Solid Tumors

For more information about the trial above please contact the study team: